WO2006104989A2
(en)
*
|
2005-03-29 |
2006-10-05 |
Verenium Corporation |
Altered antibody fc regions and uses thereof
|
KR101030978B1
(ko)
*
|
2008-07-10 |
2011-04-28 |
(주) 에이프로젠 |
동물세포용 재조합 발현벡터
|
CN101747440B
(zh)
*
|
2008-12-18 |
2014-05-07 |
嘉和生物药业有限公司 |
一种TNFR-Fc融合蛋白及其用途
|
US20110117092A1
(en)
*
|
2009-10-20 |
2011-05-19 |
The Regents Of The University Of Michigan |
Compositions and methods for inhibiting g-csfr
|
DK2526119T3
(en)
|
2010-01-19 |
2018-07-30 |
Harvard College |
Manipulated opsonin for pathogen detection and treatment
|
CN102260343A
(zh)
*
|
2010-05-25 |
2011-11-30 |
健能隆医药技术(上海)有限公司 |
重组人g-csf二聚体在治疗神经损伤疾病中的用途
|
WO2012032520A1
(en)
*
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
KR101333958B1
(ko)
|
2010-10-20 |
2013-11-27 |
주식회사 한독 |
인간 인터루킨-1 수용체 길항제-하이브리드 Fc 융합단백질
|
DE112012000404T5
(de)
|
2011-01-04 |
2014-04-17 |
Charitè Universitätsmedizin Berlin |
Modulatoren von IL-12 und/oder IL-23 zur Prävention oder Behandlung des Morbus Alzheimer
|
CN102585013B
(zh)
*
|
2011-01-07 |
2014-04-23 |
中国人民解放军军事医学科学院生物工程研究所 |
一种含有ω干扰素的融合蛋白及制备方法
|
MX2013009862A
(es)
|
2011-03-02 |
2013-10-25 |
Novo Nordisk As |
Factor de coagulacion dirigido al transcripto 1 tipo trem (tlt-1) en plaquetas activadas.
|
US10400029B2
(en)
|
2011-06-28 |
2019-09-03 |
Inhibrx, Lp |
Serpin fusion polypeptides and methods of use thereof
|
CN110551223A
(zh)
*
|
2011-06-28 |
2019-12-10 |
英伊布里克斯有限合伙公司 |
丝氨酸蛋白酶抑制蛋白融合多肽及其使用方法
|
WO2013012924A2
(en)
|
2011-07-18 |
2013-01-24 |
President And Fellows Of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
AU2012289433B2
(en)
*
|
2011-07-25 |
2017-07-27 |
Evive Biotechnology (Shanghai) Ltd |
Use of G-CSF dimer in preparation of medicament for treatment of neurodegenerative diseases
|
KR20130049671A
(ko)
|
2011-11-04 |
2013-05-14 |
한미사이언스 주식회사 |
생리활성 폴리펩타이드 결합체 제조 방법
|
SG10202001596VA
(en)
|
2011-12-19 |
2020-04-29 |
Univ Rockefeller |
Non-sialylated anti-inflammatory polypeptides
|
WO2016141262A1
(en)
|
2015-03-04 |
2016-09-09 |
The Rockefeller University |
Anti-inflammatory polypeptides
|
KR101183615B1
(ko)
*
|
2011-12-28 |
2012-09-17 |
재단법인 경기과학기술진흥원 |
Wnt에 결합하는 신규한 재조합 단백질
|
AR090281A1
(es)
|
2012-03-08 |
2014-10-29 |
Hanmi Science Co Ltd |
Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo
|
WO2013138338A2
(en)
|
2012-03-12 |
2013-09-19 |
Massachusetts Institute Of Technology |
Methods for treating tissue damage associated with ischemia with apoliporotein d
|
BR112014026162A2
(pt)
*
|
2012-04-23 |
2017-10-03 |
Nrl Pharma Inc |
Proteína de fusão ou variante da mesma, molécula de ácido nucleico, vetor de expressão, célula hospedeira, animal não humano geneticamente modificado, planta geneticamente modificada, agente terapêutico para doenças melhoradas por lactoferrina, composição farmacêutica, e, método para preparar a proteína de fusão ou variante da mesma
|
CN104870019A
(zh)
|
2012-11-27 |
2015-08-26 |
阿特根公司 |
用于稳定蛋白质和Fc结构域融合的融合蛋白的组合物
|
TWI635098B
(zh)
*
|
2013-02-01 |
2018-09-11 |
再生元醫藥公司 |
含嵌合恆定區之抗體
|
EP2956003A2
(en)
|
2013-02-13 |
2015-12-23 |
Laboratoire Français du Fractionnement et des Biotechnologies |
Proteins with modified glycosylation and methods of production thereof
|
MX2015010427A
(es)
|
2013-02-13 |
2016-03-17 |
Lab Francais Du Fractionnement |
Anticuerpos anti-tnf-alfa altamente galactosilados y sus usos.
|
JP2016511275A
(ja)
*
|
2013-03-11 |
2016-04-14 |
ノヴォ・ノルディスク・ヘルス・ケア・アーゲー |
成長ホルモン化合物
|
SG11201506335YA
(en)
*
|
2013-03-14 |
2015-09-29 |
Regeneron Pharma |
Apelin fusion proteins and uses thereof
|
ES2708565T3
(es)
|
2013-03-15 |
2019-04-10 |
Atyr Pharma Inc |
Conjugados de Fc-histidil-ARNt sintetasa
|
US10551379B2
(en)
|
2013-03-15 |
2020-02-04 |
President And Fellows Of Harvard College |
Methods and compositions for improving detection and/or capture of a target entity
|
EP2992017B1
(en)
|
2013-05-02 |
2020-11-18 |
AnaptysBio, Inc. |
Antibodies directed against programmed death-1 (pd-1)
|
AU2014268603B2
(en)
|
2013-05-21 |
2018-03-22 |
President And Fellows Of Harvard College |
Engineered heme-binding compositions and uses thereof
|
KR101895634B1
(ko)
*
|
2013-05-31 |
2018-09-05 |
한미약품 주식회사 |
변이된 힌지 영역을 포함하는 IgG4 Fc 단편
|
AR096890A1
(es)
*
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugando fc de inmunoglobulina, que mantiene la afinidad de unión del fragmento fc de la inmunoglobulina a fcrn
|
CN104231086B
(zh)
*
|
2013-08-27 |
2019-12-13 |
北京韩美药品有限公司 |
双功能融合蛋白及其制备方法和用途
|
EP3038657A2
(en)
|
2013-08-28 |
2016-07-06 |
Bioasis Technologies Inc. |
Cns-targeted conjugates having modified fc regions and methods of use thereof
|
MA39061A1
(fr)
|
2013-11-20 |
2017-10-31 |
Regeneron Pharma |
Modulateurs d'aplnr et leurs utilisations
|
EP3912986B1
(en)
|
2013-12-18 |
2023-12-13 |
President and Fellows of Harvard College |
Crp capture/detection of bacteria
|
TWI754319B
(zh)
|
2014-03-19 |
2022-02-01 |
美商再生元醫藥公司 |
用於腫瘤治療之方法及抗體組成物
|
SG10202107752PA
(en)
*
|
2014-03-31 |
2021-09-29 |
Hanmi Pharmaceutical Co Ltd |
Method for improving solubility of protein and peptide by using immunoglobulin fc fragment linkage
|
KR20150135148A
(ko)
*
|
2014-05-23 |
2015-12-02 |
주식회사 제넥신 |
Pd-l1 융합 단백질 및 이의 용도
|
KR20170040132A
(ko)
|
2014-06-02 |
2017-04-12 |
라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 |
Fc 단편의 제조
|
US10441595B2
(en)
*
|
2014-06-26 |
2019-10-15 |
Brigham Young University |
Methods for treating fungal infections
|
KR102272213B1
(ko)
*
|
2014-07-08 |
2021-07-01 |
삼성전자주식회사 |
표적화 부위, 절단 부위, 및 세포막 투과 부위를 포함하는 융합 단백질 및 그의 용도
|
TW201629100A
(zh)
*
|
2014-10-06 |
2016-08-16 |
格納西尼有限公司 |
人類IgG4 Fc多肽變異體
|
EP3699198A1
(en)
|
2014-11-17 |
2020-08-26 |
Regeneron Pharmaceuticals, Inc. |
Methods for tumor treatment using cd3xcd20 bispecific antibody
|
KR102569813B1
(ko)
|
2014-11-21 |
2023-08-24 |
브리스톨-마이어스 스큅 컴퍼니 |
Cd73에 대항한 항체 및 그의 용도
|
EP3789399A1
(en)
|
2014-11-21 |
2021-03-10 |
Bristol-Myers Squibb Company |
Antibodies comprising modified heavy constant regions
|
MA40662B1
(fr)
|
2014-12-23 |
2020-12-31 |
Bristol Myers Squibb Co |
Anticorps contre tigit
|
KR101825048B1
(ko)
*
|
2014-12-31 |
2018-02-05 |
주식회사 제넥신 |
GLP 및 면역글로불린 하이브리드 Fc 융합 폴리펩타이드 및 이의 용도
|
CN110204617B
(zh)
*
|
2014-12-31 |
2023-06-16 |
天境生物科技(上海)有限公司 |
含胰高血糖素样肽-1和免疫球蛋白杂合Fc的融合多肽及其用途
|
CN114159552A
(zh)
*
|
2015-01-09 |
2022-03-11 |
格纳西尼有限公司 |
使用长效epo配制物治疗贫血的方法
|
JP6773679B2
(ja)
|
2015-03-30 |
2020-10-21 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. |
Fcガンマ受容体に対する結合が低下した重鎖定常領域
|
PL3288965T3
(pl)
*
|
2015-04-29 |
2019-11-29 |
Mediolanum Farm S P A |
Rozpuszczalny chimeryczny receptor interleukiny-10 i jego zastosowanie terapeutyczne
|
US20180139938A1
(en)
|
2015-05-04 |
2018-05-24 |
Laboratoire Français du Fractionnement et des, Biotechnologies |
Transgenic production of fc fusion proteins
|
WO2016178087A1
(en)
|
2015-05-04 |
2016-11-10 |
Biosourcing Sa |
Transgenic production of chorionic gonadotropin
|
AR105616A1
(es)
*
|
2015-05-07 |
2017-10-25 |
Lilly Co Eli |
Proteínas de fusión
|
MY188049A
(en)
|
2015-05-29 |
2021-11-12 |
Bristol Myers Squibb Co |
Antibodies against ox40 and uses thereof
|
JP6983075B2
(ja)
|
2015-06-02 |
2021-12-17 |
ノヴォ ノルディスク アー/エス |
極性の組換え延長部を有するインスリン
|
US10208099B2
(en)
*
|
2015-06-11 |
2019-02-19 |
Genexine, Inc. |
Modified interleukin-7 protein
|
EA201890162A1
(ru)
|
2015-06-29 |
2018-07-31 |
Бристол-Маерс Сквибб Компани |
Антитела к cd40 с повышенной агонистической активностью
|
CN108289928A
(zh)
|
2015-08-06 |
2018-07-17 |
哈佛大学校长及研究员协会 |
改进的微生物-结合分子和其用途
|
MA43348A
(fr)
|
2015-10-01 |
2018-08-08 |
Novo Nordisk As |
Conjugués de protéines
|
KR101773858B1
(ko)
|
2015-10-23 |
2017-09-01 |
명지대학교 산학협력단 |
피부 주름 개선용 조성물
|
KR102147997B1
(ko)
*
|
2015-10-23 |
2020-08-25 |
주식회사 제넥신 |
피부 주름 개선용 조성물
|
KR20170049319A
(ko)
*
|
2015-10-28 |
2017-05-10 |
주식회사유한양행 |
지속형 fgf21 융합 단백질 및 이를 포함하는 약학적 조성물
|
KR102386735B1
(ko)
*
|
2015-11-06 |
2022-04-14 |
주식회사 제넥신 |
변형된 인터루킨-7 융합 단백질의 제형
|
CN108697764A
(zh)
*
|
2015-12-04 |
2018-10-23 |
格纳西尼有限公司 |
含有免疫球蛋白fc融合白细胞介素-7融合蛋白的用于预防或治疗流感病毒感染的药物组合物
|
TWI774651B
(zh)
|
2015-12-04 |
2022-08-21 |
南韓商吉耐森股份有限公司 |
包含融合有免疫球蛋白Fc之介白素-7的用於預防或治療人類乳頭狀瘤病毒相關疾病的藥學組成物
|
AR107483A1
(es)
|
2016-01-29 |
2018-05-02 |
Hanmi Pharm Ind Co Ltd |
Conjugado de enzimas terapéuticas
|
WO2017142331A1
(en)
|
2016-02-17 |
2017-08-24 |
Genexine, Inc. |
Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency
|
BR112018016817A2
(pt)
*
|
2016-02-17 |
2018-12-26 |
Genexine Inc |
composição farmacêutica e método de tratamento da deficiência do hormônio do crescimento
|
EP3423489A1
(en)
|
2016-03-04 |
2019-01-09 |
The Rockefeller University |
Antibodies to cd40 with enhanced agonist activity
|
SG10201913033UA
(en)
|
2016-03-04 |
2020-03-30 |
Bristol Myers Squibb Co |
Combination therapy with anti-cd73 antibodies
|
KR20170123849A
(ko)
*
|
2016-04-29 |
2017-11-09 |
주식회사유한양행 |
Ccl3 변이체를 포함하는 융합 단백질 및 이의 용도
|
SG11201810023QA
(en)
|
2016-05-27 |
2018-12-28 |
Agenus Inc |
Anti-tim-3 antibodies and methods of use thereof
|
CN106191072A
(zh)
*
|
2016-08-04 |
2016-12-07 |
沈沭彤 |
重组人源嵌合GcFc基因片段及融合蛋白
|
JOP20190019A1
(ar)
*
|
2016-08-30 |
2019-02-12 |
Genexine Inc |
تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH)
|
EP3533870A4
(en)
|
2016-10-28 |
2020-04-08 |
NRL Pharma, Inc. |
LACTOFERRIN / ALBUMIN FUSION PROTEIN AND PRODUCTION METHOD THEREFOR
|
AU2017354070A1
(en)
|
2016-11-01 |
2019-05-16 |
Anaptysbio, Inc. |
Antibodies directed against programmed death- 1 (PD-1)
|
CN110461880A
(zh)
*
|
2016-11-10 |
2019-11-15 |
科乐斯疗法公司 |
Gdnf融合多肽及其使用方法
|
CN108264562B
(zh)
*
|
2016-12-30 |
2021-08-10 |
惠和生物技术(上海)有限公司 |
一种结合cd3和t细胞正共刺激分子的双功能分子及其应用
|
BR112019014187A2
(pt)
|
2017-01-09 |
2020-02-11 |
Tesaro, Inc. |
Métodos de tratamento de câncer com anticorpos anti-pd-1
|
CN106832002A
(zh)
*
|
2017-02-16 |
2017-06-13 |
上海科医联创生物科技有限公司 |
一种靶向pd‑1的融合蛋白及其相关应用
|
CN110785435B
(zh)
|
2017-03-06 |
2024-01-23 |
艾尔特生物科技公司 |
与il-12和il-18的基于il-15的融合物
|
CN108623692B
(zh)
*
|
2017-03-20 |
2020-11-17 |
徐寒梅 |
一种融合蛋白及其制备方法和其应用
|
WO2018185131A2
(en)
|
2017-04-05 |
2018-10-11 |
Novo Nordisk A/S |
Oligomer extended insulin-fc conjugates
|
TWI788340B
(zh)
|
2017-04-07 |
2023-01-01 |
美商必治妥美雅史谷比公司 |
抗icos促效劑抗體及其用途
|
WO2018195338A1
(en)
|
2017-04-20 |
2018-10-25 |
Atyr Pharma, Inc. |
Compositions and methods for treating lung inflammation
|
JP7191850B2
(ja)
|
2017-04-21 |
2022-12-19 |
ユーハン・コーポレイション |
デュアル機能タンパク質およびその誘導体を生産するための方法
|
CA3064321A1
(en)
|
2017-05-25 |
2018-11-29 |
Bristol-Myers Squibb Company |
Antibodies comprising modified heavy constant regions
|
CN107082815A
(zh)
*
|
2017-06-28 |
2017-08-22 |
杭州皓阳生物技术有限公司 |
一种fsh‑hsa融合蛋白及其制备方法
|
US11883503B2
(en)
|
2017-09-25 |
2024-01-30 |
Dingfu Biotarget Co., Ltd. |
Methods and compositions for cancer treatment
|
MX2020003672A
(es)
|
2017-09-27 |
2020-08-03 |
Epicentrx Inc |
Proteinas de fusion inmunomoduladora.
|
NZ765453A
(en)
*
|
2017-12-22 |
2024-03-22 |
Hanmi Pharmaceutical Co Ltd |
Therapeutic enzyme fusion protein having novel structure and use thereof
|
WO2019133747A1
(en)
|
2017-12-27 |
2019-07-04 |
Bristol-Myers Squibb Company |
Anti-cd40 antibodies and uses thereof
|
WO2019135666A1
(ko)
*
|
2018-01-08 |
2019-07-11 |
주식회사 프로젠 |
Ige fc 수용체의 알파 서브유닛의 세포외 도메인을 포함하는 약학적 조성물
|
PE20210043A1
(es)
*
|
2018-01-08 |
2021-01-08 |
Gi Innovation Inc |
Dominio extracelular de subunidad alfa del receptor fc de ige, composicion farmaceutica que comprende el mismo y metodo para producir el mismo
|
KR102038679B1
(ko)
|
2018-01-12 |
2019-10-30 |
(주)지아이이노베이션 |
프로바이오틱스 및 IgE에 결합능이 있는 폴리펩티드를 포함하는 조성물 및 이의 용도
|
CN110054700A
(zh)
*
|
2018-01-18 |
2019-07-26 |
分子克隆研究室有限公司 |
长效治疗性融合蛋白
|
CN112041333A
(zh)
|
2018-04-26 |
2020-12-04 |
古德T细胞有限公司 |
新型融合蛋白和用于预防或治疗癌症的包含该融合蛋白的药物组合物
|
US20210121529A1
(en)
|
2018-05-04 |
2021-04-29 |
Ilkogen Ilaç Sanayi Ve Ticaret A.S. |
Stable hybrid fc fusion g-csf formulation
|
US20210347849A1
(en)
|
2018-07-24 |
2021-11-11 |
Good T Cells, Inc. |
Composition for Preventing or Treating Immune-Related Diseases
|
KR20200011685A
(ko)
|
2018-07-25 |
2020-02-04 |
주식회사유한양행 |
갑상선 자극 호르몬 수용기(thyrotropin receptor, TSHR) 단편을 포함하는 융합 단백질 및 이의 용도
|
JP2021535142A
(ja)
|
2018-08-31 |
2021-12-16 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. |
Cd3/c20二重特異性抗体のサイトカイン放出症候群を軽減する投与戦略
|
KR102263105B1
(ko)
*
|
2018-09-05 |
2021-06-09 |
주식회사 엘지화학 |
O-글리코실화 가능한 폴리펩타이드 영역을 포함하는 융합 폴리펩타이드
|
WO2020053661A1
(en)
|
2018-09-13 |
2020-03-19 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Methods of purifying antibodies from the milk of transgenic non-human mammals comprising the use of chitosan
|
US20220008515A1
(en)
|
2018-11-16 |
2022-01-13 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of il-7 protein and an immune checkpoint inhibitor
|
EP3887397A1
(en)
|
2018-11-28 |
2021-10-06 |
Bristol-Myers Squibb Company |
Antibodies comprising modified heavy constant regions
|
EP3923973B1
(en)
|
2019-02-13 |
2023-02-01 |
Ilkogen Ilaç Sanayi ve Ticaret A.S. |
A long-acting g-csf for preventing neutropenia or reducing duration of neutropenia
|
WO2020184941A1
(en)
*
|
2019-03-08 |
2020-09-17 |
Genexine, Inc. |
Glp-1 fusion proteins and uses thereof
|
AU2020273903B2
(en)
*
|
2019-05-14 |
2024-05-09 |
Progen Co Ltd |
Novel modified immunoglobulin Fc-fusion protein and use thereof
|
DK3744319T3
(da)
|
2019-05-28 |
2023-01-16 |
Ilkogen Ilac Sanayi Ve Ticaret A S |
Stabil lyofiliseret formulering til hybrid fc-fusioneret g-csf
|
US20220267396A1
(en)
|
2019-07-08 |
2022-08-25 |
Progen Co., Ltd. |
Novel il-10 variant protein and use thereof
|
MX2022000285A
(es)
*
|
2019-07-08 |
2022-02-03 |
Gi Innovation Inc |
Dimero de polipeptido con alto contenido de acido sialico, que comprende el dominio extracelular de la subunidad alfa del receptor fc de ige y composicion farmaceutica que comprende el mismo.
|
WO2021006375A1
(ko)
*
|
2019-07-08 |
2021-01-14 |
(주)지아이이노베이션 |
Ige fc 수용체의 알파 서브유닛의 세포외 도메인을 포함하는 시알산 함량이 높은 폴리펩티드 이량체 및 이를 포함하는 약학적 조성물
|
WO2021006603A1
(ko)
*
|
2019-07-08 |
2021-01-14 |
주식회사 프로젠 |
신규 알러지 질환 치료용 약학적 조성물
|
EP3998282A4
(en)
*
|
2019-07-08 |
2023-08-09 |
Progen Co., Ltd. |
NEW FUSION PROTEIN AND ITS USE
|
AU2020400805B2
(en)
*
|
2019-12-11 |
2024-03-28 |
Lg Chem, Ltd. |
Fusion polypeptide comprising GDF15 and polypeptide region capable of O-glycosylation
|
CN111057154B
(zh)
*
|
2019-12-23 |
2023-06-06 |
南京融捷康生物科技有限公司 |
基于驼源Fc片段的免疫原的制备及应用
|
JP2023512456A
(ja)
|
2020-01-13 |
2023-03-27 |
ネオイミューンテック, インコーポレイテッド |
Il-7タンパク質と二重特異性抗体の組み合わせで腫瘍を治療する方法
|
EP4186517A1
(en)
*
|
2020-01-23 |
2023-05-31 |
Genexine, Inc. |
Fusion protein comprising pd-l1 protein and use thereof
|
WO2021158783A1
(en)
|
2020-02-05 |
2021-08-12 |
Washington University |
Method of treating a solid tumor with a combination of an il-7 protein and car-bearing immune cells
|
WO2021182928A1
(ko)
|
2020-03-12 |
2021-09-16 |
주식회사 에스엘메타젠 |
신규 이중 특이성 단백질 및 그의 용도
|
KR20210141406A
(ko)
*
|
2020-05-14 |
2021-11-23 |
주식회사 프로젠 |
신규 재조합 융합단백질 및 그의 용도
|
WO2021231732A1
(en)
|
2020-05-15 |
2021-11-18 |
Bristol-Myers Squibb Company |
Antibodies to garp
|
WO2022000136A1
(en)
*
|
2020-06-28 |
2022-01-06 |
Dingfu Biotarget Co., Ltd. |
Methods and compositions for cancer treatment
|
CN111944058B
(zh)
*
|
2020-07-28 |
2021-12-17 |
中国农业大学 |
一种兼具抗菌、抗炎、中和内毒素和免疫调节活性的多功能杂合肽及其制备方法和应用
|
WO2022080912A1
(ko)
*
|
2020-10-16 |
2022-04-21 |
주식회사 아이엠바이오로직스 |
IgM 영역을 이용한 융합단백질 플랫폼
|
EP4232070A1
(en)
|
2020-10-26 |
2023-08-30 |
NeoImmuneTech, Inc. |
Methods of inducing stem cell mobilization
|
WO2022094475A1
(en)
|
2020-11-02 |
2022-05-05 |
Neoimmunetech, Inc. |
Use of interleukin-7 for the treatment of coronavirus
|
EP4240408A1
(en)
|
2020-11-05 |
2023-09-13 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of an il-7 protein and a nucleotide vaccine
|
WO2022131889A1
(ko)
|
2020-12-16 |
2022-06-23 |
주식회사 굳티셀 |
Taci 단백질의 용도
|
CA3211978A1
(en)
|
2021-03-09 |
2022-09-15 |
Gi Innovation, Inc. |
Formulation of fusion protein including extracellular domain of alpha subunit of ige fc receptor
|
CN113603791A
(zh)
*
|
2021-08-11 |
2021-11-05 |
厦门目青股权投资合伙企业(有限合伙) |
一种融合蛋白及其应用
|
WO2023130081A1
(en)
|
2021-12-30 |
2023-07-06 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of il-7 protein and vegf antagonist
|
WO2023173084A1
(en)
|
2022-03-11 |
2023-09-14 |
University Of Rochester |
Cyclopeptibodies and uses thereof
|
CN115850517A
(zh)
*
|
2022-11-14 |
2023-03-28 |
沈阳药科大学 |
一种提高GLP-1 Fc融合蛋白产量的方法
|